BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35737871)

  • 1. Cancer bone metastases and nanotechnology-based treatment strategies.
    Li Z; Zhang W; Zhang Z; Gao H; Qin Y
    Expert Opin Drug Deliv; 2022 Oct; 19(10):1217-1232. PubMed ID: 35737871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Nanomedicine for the Diagnosis and Treatment of Prostate Cancer Bone Metastasis.
    Hagaman DE; Damasco JA; Perez JVD; Rojo RD; Melancon MP
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33450939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology and nanomedicine: going small means aiming big.
    Teli MK; Mutalik S; Rajanikant GK
    Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
    Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
    J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanotechnology-based intelligent drug design for cancer metastasis treatment.
    Gao Y; Xie J; Chen H; Gu S; Zhao R; Shao J; Jia L
    Biotechnol Adv; 2014; 32(4):761-77. PubMed ID: 24211475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Applications of Nanotechnology in Drug Delivery and Medical Imaging: Review.
    Singh S; Sharma H
    Curr Radiopharm; 2023; 16(4):269-283. PubMed ID: 37345242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted Nanotechnology from Bench to Bedside.
    Sapalidis K; Kosmidis C; Laskou S; Katsaounis A; Mantalobas S; Passos I; Michalopoulos N; Amaniti A; Sardeli C; Zarogoulidis P
    Curr Cancer Drug Targets; 2019; 19(1):3-4. PubMed ID: 30672409
    [No Abstract]   [Full Text] [Related]  

  • 9. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology-integrated ovarian cancer metastasis therapy: Insights from the metastatic mechanisms into administration routes and therapy strategies.
    Huang Y; Li C; Zhang X; Zhang M; Ma Y; Qin D; Tang S; Fei W; Qin J
    Int J Pharm; 2023 Apr; 636():122827. PubMed ID: 36925023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green nanomedicine: the path to the next generation of nanomaterials for diagnosing brain tumors and therapeutics?
    Mostafavi E; Medina-Cruz D; Vernet-Crua A; Chen J; Cholula-Díaz JL; Guisbiers G; Webster TJ
    Expert Opin Drug Deliv; 2021 Jun; 18(6):715-736. PubMed ID: 33332168
    [No Abstract]   [Full Text] [Related]  

  • 12. Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine.
    Jang SF; Liu WH; Song WS; Chiang KL; Ma HI; Kao CL; Chen MT
    Int J Mol Sci; 2014 Mar; 15(3):3904-25. PubMed ID: 24599081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artificial intelligence aids in development of nanomedicines for cancer management.
    Tan P; Chen X; Zhang H; Wei Q; Luo K
    Semin Cancer Biol; 2023 Feb; 89():61-75. PubMed ID: 36682438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine.
    Egwu CO; Aloke C; Onwe KT; Umoke CI; Nwafor J; Eyo RA; Chukwu JA; Ufebe GO; Ladokun J; Audu DT; Agwu AO; Obasi DC; Okoro CO
    Molecules; 2024 May; 29(11):. PubMed ID: 38893460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and Opportunities from Basic Cancer Biology for Nanomedicine for Targeted Drug Delivery.
    Xie X; Zhang Y; Li F; Lv T; Li Z; Chen H; Jia L; Gao Y
    Curr Cancer Drug Targets; 2019; 19(4):257-276. PubMed ID: 29956629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Bone Metastasis: A Narrative Review of Emerging Targeted Drug Delivery Systems.
    Shao H; Varamini P
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Era on Combining Both Imaging and Drug Delivery to Treat Cancer.
    Siafaka P; Çağlar EŞ; Gündoğdu EA; Okur NÜ
    Curr Pharm Biotechnol; 2023; 24(7):832-855. PubMed ID: 35718984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology based therapeutics for lung disease.
    Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
    Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomedicine and drug delivery systems in cancer and regenerative medicine.
    Garbayo E; Pascual-Gil S; Rodríguez-Nogales C; Saludas L; Estella-Hermoso de Mendoza A; Blanco-Prieto MJ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1637. PubMed ID: 32351045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.
    Occhiutto ML; Maranhão RC; Costa VP; Konstas AG
    Adv Ther; 2020 Jan; 37(1):155-199. PubMed ID: 31823205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.